Leukemia Myelomonocytic Chronic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-09-23
Clinical Trial Update: An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML) [Phase 2]
Phase 2 trial evaluating pevonedistat plus azacitidine versus azacitidine alone in higher-risk myelodysplastic syndromes, chronic myelomonoc…